市場調査レポート
商品コード
1138384

妊活サプリメントの世界市場-2022-2029

Global Fertility Supplements Market - 2022-2029

出版日: | 発行: DataM Intelligence | ページ情報: 英文 180 Pages | 納期: 約2営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.53円
妊活サプリメントの世界市場-2022-2029
出版日: 2022年10月18日
発行: DataM Intelligence
ページ情報: 英文 180 Pages
納期: 約2営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

市場力学

天然素材に対する需要の高まりが市場成長を牽引。

妊活サプリメントの需要は、予測期間中に増加すると予想されています。高齢者人口の増加や予防医療ソリューションへの関心の高まりは、世界的に市場の成長を促す特定の要因となっています。教育制度の向上に伴い、天然成分への嗜好が高まっています。レッドクローバー、サクラソウオイル、ブドウ種子抽出物などの成分を含む妊活サプリメントの需要が明らかに増加しています。このような取り組みは、市場全体の成長にも好影響を与えると思われます。

さらに、医師は不妊の悩みに対し、しばしば妊活サプリメントを推奨しています。これは、世界市場にプラスの影響を与えることが期待されます。

目次

第1章 調査手法と範囲

  • 調査手法
  • 市場の範囲

第2章 主な動向と発展

第3章 エグゼクティブサマリー

  • 成分別市場内訳
  • 製品別市場内訳
  • エンドユーザー別市場内訳
  • 地域別市場内訳

第4章 市場力学

  • 市場影響要因
    • 促進要因
      • 天然素材に対する需要の高まりがプラスに作用
      • 家族計画に関する規制の改正により、中国とその他の地域での成長が促進される
    • 抑制要因
      • 副作用に関する懸念の増加
    • ビジネスチャンス
  • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • バリューチェーン分析
  • 特許分析
  • 規制分析

第6章 COVID-19の分析

  • COVID-19の市場分析
    • COVID-19以前の市場シナリオ
    • COVID-19の現在の市場シナリオ
    • COVID-19の後、または将来のシナリオ
  • COVID-19の中での価格ダイナミクス
  • 需要-供給スペクトラム
  • パンデミック時の市場に関連する政府の取り組み
  • メーカーの戦略的取り組み

第7章 成分別

  • 天然
  • 合成/天然と合成のブレンド

第8章 製品別

  • カプセル
  • 粉末
  • 錠剤
  • ソフトジェル
  • 液体

第9章 エンドユーザー別

  • 男性
  • 女性

第10章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 南米
    • ブラジル
    • アルゼンチン
    • その他の南米地域
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他の欧州地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ地域

第11章 競合情勢

  • 競合シナリオ
  • 競合他社の戦略分析
  • 市況/シェア分析
  • M&A(合併・買収)分析

第12章 企業プロファイル

  • Fairhaven Lenus
    • 企業概要
    • 製品ポートフォリオと説明
    • 主なハイライト
    • 財務概要
  • Coast Science Lenus
  • Pharma GmbH
  • Active Bio Life Science GmbH
  • Orthomol
  • Exeltis USA, Inc.
  • PregPrep LLC
  • TTK Healthcare Ltd.
  • Bestmade Natural Products
  • Shenzhen Hemp Bio-Tech Co., Ltd
  • CURIVO HEALTHCARE LLP
  • NUTRIFACTOR LABORATORIES(PVT.)LIMITED
  • Xiamen Yuanzhidao Biotechnology Co., Ltd.

第13章 DataM

目次
Product Code: DMHCIT3077

Market Overview

Fertility Supplements Market size was valued at USD 1,977.30 million in 2021 and is estimated to reach at a compound annual growth rate (CAGR) of 9.60% over the forecast period 2022 to 2029.

Fertility assists in producing offspring; however, in certain cases, failure in this process leads to infertility. To overcome such issues, there has been developed by pharmaceutical companies with the introduction of medicines in the form of soft gels, capsules, powders, liquids, and others. These drugs assist in treating infertility problems in men and women. Fertility supplements, also termed fertility drugs, are medications that improve reproductive fertility. For women, a fertility supplement is used to promote follicle development of the ovary. The increasing embracing of herbal medicines due to the rising concerns involving the harmful effects linked with conventional pharma drugs is likely to create growth opportunities for product manufacturers. Several government initiatives for generating awareness about innovations in supplement research and superior technology have helped consumers make supplement choices.

Market Dynamics: Rising Demand for Natural Ingredients drives market growth.

The demand for fertility supplements is expected to rise over the forecast period. The rising geriatric population and the increasing interest in preventive healthcare solutions are certain factors encouraging the growth of the market across the globe. With the rise in the education system, there is a rise in the preference for natural ingredients. There is an apparent rise in the demand for fertility supplements that contain ingredients, such as red clover, primrose oil, or grape seed extracts. These efforts are likely to have an encouraging impact on the overall market growth.

Moreover, doctors often recommend fertility supplements to assist couples and parents cope with their fertility concerns. This is expected to have a positive impact on the global market.

However, amendments in family planning regulations in China. With the introduction of the "one-child-per-couple" policy in China, the fertility of women has been negatively impacted.

Market Segmentation: The powder segment accounted for the highest share in global fertility supplements market.

The fertility supplements market has been classified into capsules, tablets, soft gels, powders, and liquids based on the product.

The fertility supplement powder segment dominated the market in 2022. It is owing to increasing awareness regarding the nutritional benefits linked with these products. These products facilitate unique mixes of ingredients, reduce gastrointestinal irritation, and ensure oil and fat-soluble nutrient delivery.

Based on the end-users, the fertility supplements market has been classified into men and women. The men segment accounted significant market share in the fertility supplements market during the forecast period. Immune system factors, varicocele, hypogonadism, systemic disease, urogenital infection, sexual factors, and undescended testicles are some of the major factors leading to fertility problems in men. In the last 50 years, sperm concentration has fallen considerably by 52% among men in Western countries. The drop is alarming as sperm concentration below 40 million per milliliter is considered below normal and can worsen fertility. All these factors have resulted in an increasing demand for fertility supplements for men.

Geographical Penetration: North America is the dominating region during the forecast period.

North America contributed the largest revenue share to the global fertility supplements market in 2022. This dominance is due to the presence of several key market players in the region, especially in the US. Moreover, the increasing health concerns among consumers further support the market growth in the region. Additionally, the growing prevalence of obesity and the rising number of diabetic patients in the region is augmenting the demand for fertility supplements in North America. However, Asia Pacific is projected to grow at the fastest CAGR in the global fertility supplements market over the forecast period. This growth is attributed to the change in the lifestyle of customers and the increase in health consciousness among the consumers. The market in this region is observing a radical transformation regarding rapid urbanization, diet diversification, and liberal trade policies in the food sector. Furthermore, an increase in the inclination of consumers toward healthy food products and a surge in purchasing power are certain factors offering growth opportunities for fertility supplements manufacturers in the region.

Competitive Landscape:

The fertility supplements market is highly competitive, owing to the presence of big food brands. The critical fertility supplements players which are contributing to the growth of the global market include Fairhaven Health, Coast Science Lenus, Pharma GesmbH, Active Bio Life Science GmbH, Orthomol Exeltis USA, Inc. PregPrep LLC, TTK Healthcare Ltd., Best made Natural Products, Curivo Healthcare Llp, Nutrifactor Laboratories (Pvt.) Limited, Xiamen Yuanzhidao Biotechnology Co., Ltd. and Shenzhen Hemp Bio-Tech Co., Ltd., among others. The major players are adopting new launches based on new material launches and expansion strategies for global growth in the fertility supplements market. In August 2022, Youtheory, a supplement brand, expanded its new line of liquid dietary supplements. This company is acquired by Canadian firm Jamieson wellness in a deal of $210 million. In April 2022, Ovaterra launched New Prenatal Vitamins in the market for fertility treatment. The supplements, designed in collaboration with fertility author Rebecca Fett, contain the full recommended daily allowance of choline. These two supplements are named Advanced Prenatal and Advanced Prep 35-39. Advanced Prep 35-39 includes 25mg of patented FERTINATAL, a micronized DHEA and is designed specifically for women aged 35-39, the more advanced reproductive age range.

COVID-19 Impact: Positive impact on the global fertility supplements market.

COVID-19 has led to an increase in fertility supplements amidst the pandemic. The company engaged in the fertility supplements market has witnessed a nominal surge in revenue during the pandemic. This is because COVID-19 certainly impacts the fertility level of a person, owing to which an intake of supplements has increased for fertility supplements post the outbreak of COVID-19.

Table of Contents

1. Scope and Methodology

  • 1.1. Research Methodology
  • 1.2. Scope of the Market

2. Key Trends and Developments

3. Executive Summary

  • 3.1. Market Snippet by Ingredients
  • 3.2. Market Snippet by Product
  • 3.3. Market Snippet by End Use
  • 3.4. Market Snippet by Region

4. Market Dynamics

  • 4.1. Market impacting factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rising Demand for Natural Ingredients to Have a Positive Impact
      • 4.1.1.2. Amendments in Family Planning Regulations to Propel Growth in China and Elsewhere
    • 4.1.2. Restraints
      • 4.1.2.1. Increasing concerns regarding the side effects
    • 4.1.3. Opportunities
  • 4.2. Impact analysis

5. Industry Analysis

  • 5.1. Porter's five forces analysis
  • 5.2. Value chain analysis
  • 5.3. Patent Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives

7. By Ingredients

  • 7.1. Introduction
    • 7.1.1. Market size analysis, and y-o-y growth analysis (%), By Ingredients Segment
    • 7.1.2. Market attractiveness index, By Ingredients Segment
  • 7.2. Natural *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2020-2029 And Y-O-Y Growth Analysis (%), 2021-2029
  • 7.3. Synthetic/Blend of Natural & Synthetic

8. By Product

  • 8.1. Introduction
    • 8.1.1. Market size analysis, and y-o-y growth analysis (%), By Product Segment
    • 8.1.2. Market attractiveness index, By Product Segment
  • 8.2. Capsules *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 And Y-O-Y Growth Analysis (%), 2021-2029
  • 8.3. Powder
  • 8.4. Tablets
  • 8.5. Soft gels
  • 8.6. Liquids

9. By End User

  • 9.1. Introduction
    • 9.1.1. Market size analysis, and y-o-y growth analysis (%), By End User Segment
    • 9.1.2. Market attractiveness index, By End User Segment
  • 9.2. Men *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2020-2029 And Y-O-Y Growth Analysis (%), 2021-2029
  • 9.3. Women

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key region-specific dynamics
    • 10.2.3. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Ingredients
    • 10.2.4. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Product
    • 10.2.5. Market Size Analysis, And Y-O-Y Growth Analysis (%), By End User
    • 10.2.6. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. South America
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Ingredients
    • 10.3.4. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Product
    • 10.3.5. Market Size Analysis, And Y-O-Y Growth Analysis (%), By End User
    • 10.3.6. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Country
      • 10.3.6.1. Brazil
      • 10.3.6.2. Argentina
      • 10.3.6.3. Rest of South America
  • 10.4. Europe
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Ingredients
    • 10.4.4. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Product
    • 10.4.5. Market Size Analysis, And Y-O-Y Growth Analysis (%), By End User
    • 10.4.6. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Country
      • 10.4.6.1. Germany
      • 10.4.6.2. U.K.
      • 10.4.6.3. France
      • 10.4.6.4. Spain
      • 10.4.6.5. Italy
      • 10.4.6.6. Rest of Europe
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Ingredients
    • 10.5.4. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Product
    • 10.5.5. Market Size Analysis, And Y-O-Y Growth Analysis (%), By End User
    • 10.5.6. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Ingredients
    • 10.6.4. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Product
    • 10.6.5. Market Size Analysis, And Y-O-Y Growth Analysis (%), By End User

11. Competitive Landscape

  • 11.1. Competitive scenario
  • 11.2. Competitor strategy analysis
  • 11.3. Market positioning/share analysis
  • 11.4. Mergers and acquisitions analysis

12. Company Profiles

  • 12.1. Fairhaven Lenus*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. Coast Science Lenus
  • 12.3. Pharma GmbH
  • 12.4. Active Bio Life Science GmbH
  • 12.5. Orthomol
  • 12.6. Exeltis USA, Inc.
  • 12.7. PregPrep LLC
  • 12.8. TTK Healthcare Ltd.
  • 12.9. Bestmade Natural Products
  • 12.10. Shenzhen Hemp Bio-Tech Co., Ltd
  • 12.11. CURIVO HEALTHCARE LLP
  • 12.12. NUTRIFACTOR LABORATORIES (PVT.) LIMITED
  • 12.13. Xiamen Yuanzhidao Biotechnology Co., Ltd.
  • List not Exhaustive*

13. DataM

  • 13.1. Appendix
  • 13.2. About us and services
  • 13.3. Contact us